1967 - 1971 Undergraduate Student, Biology, LeMoyne College, Syracuse, NY (B.S.)
1973 - 1978 Graduate Student, Biochemistry, Syracuse University, Syracuse, NY (Ph.D)
1978 - 1980 Post-doctoral Training Fellow, Clinical Chemistry, Mayo Clinic, Rochester, MN
The molecular epidemiology of coagulation, fibrinolysis, and inflammation; emphasis on innate and adaptive immunity; all studied with respect to the etiology of atherosclerosis and coronary heart disease; cardiovascular risk prediction; murine models of atherosclerosis; and, chronic diseases of old age.
Dr. Tracy’s approach to research reflects his training in biochemistry and clinical chemistry, and his long interest in population-based science. Areas of research include the interrelationships of coagulation, fibrinolysis and inflammation, especially the innate and adaptive immune systems, in the etiology of atherosclerosis and coronary heart disease, insulin resistance and diabetes, HIV-related morbidity and mortality, and other complex diseases, as well as more broadly in the process of aging. The main tools of the laboratory are those of molecular and genetic epidemiology, in the context of multi-center studies and clinical research. More basic biochemical approaches are used in the development of new assays for epidemiological application. He has a long standing interest in disease risk modeling and risk assessment as well as in developing new biomarkers for clinical and epidemiological research. He also collaborates on studies of murine models of atherosclerosis with Dr. Sally Huber of the Pathology Department.
2001 - Present Senior Associate Dean for Research and Academic Affairs, University of Vermont College of Medicine, Burlington, VT
2000 - 2001 Interim Associate Dean for Research, University of Vermont College of Medicine, Burlington, VT1997 - Present Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1995 - 1997 Associate Director of Clinical Chemistry, Fletcher Allen Health Care, Burlington, VT1993 - 1997 Associate Professor (with tenure) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1993 - 1995 Core Laboratory Director, General Clinical Research Center and Sims Obesity and Nutrition Research Center, University of Vermont College of Medicine, Burlington, VT1988 - 1993 Assistant Professor (tenure track) of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT
1984 - 1995 Clinical Chemist, Medical Center Hospital of Vermont, Burlington, VT1984 - 1988 Research Assistant Professor of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington,VT
1983 - 1984 Assistant Professor of Pathology, University of Rochester, Rochester, NYAssistant Director, Clinical Chemistry, Strong Memorial Hospital, Rochester, NY1980 - 1983 Postdoctoral Research Fellow, Mayo Clinic, Rochester, MN Consultant, Molecular Anatomy Program, Argonne National Laboratory, Argonne, IL
1978 - 1980 Postdoctoral Training Fellow in Clinical Chemistry, Mayo Clinic, Rochester, MN
2006 - 2010 AHA Council on Epidemiology and Disease Prevention - Leadership Committee, member
2009 University Distinguished Professor - highest academic award at the University of Vermont
2006 Visiting Professor, Gill Heart Institute, University of Kentucky
2005 The Bernie Zak Award for Research - Lipoproteins and Vascular Diseases Division, American Association for Clinical Chemistry
2005 The Kelly West Lecture - University of Oklahoma Medical Center
2001 Fellow, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology2001 Distinguished Visiting Professor, Pathology Department, Emory University
1987 Diplomat of the American Board of Clinical Chemistry1987 Fellow: National Academy of Clinical Chemistry
1984 AACC Award for Outstanding Scientific Achievements by a Young Investigator; American Association for Clinical Chemistry and Boehringer Mannheim Diagnostics1979 and 1982 Young Investigator Award - Academy of Clinical Laboratory Physicians and Scientists
1979 Arnold O. Beckman Conference Fellowship - American Association for Clinical Chemistry
One article listed in June 2010 in the category "articles since 1993 that have received the most overall citations" of the New England Journal of Medicine (current Impact Factor 49.91)
Two articles in the "top 50 cited articles" in American Journal of Epidemiology (current Impact Factor 6.40)
Three articles in the "top 50 most cited articles" in Clinical Chemistry (current Impact Factor 6.11)
Two articles in the "top 50 most cited articles" in Circulation (current Impact Factor 13.54)
Two articles in the "top 50 most cited articles" in Arteriosclerosis, Thrombosis and Vascular Biology (current Impact Factor 7.58).2011 Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, Tracy RP, Corey L, Deeks SG.Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis. 2011 May 15;203(10):1474-83.
2011 Duprez DA*, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD. N-terminal-prob-type natriuretic peptide predicts cardiovascular disease events in hiv-infected patients. AIDS. 25(5):651-657, 2011. (PMCID: PMC3113476).
2011 Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol Biol Sci Med Sci., 66(4): 421-9, 2011. (PMCID: PMC3055278).
2010 Carty CL, Heagerty P, Heckbert SR, Jarvik JP, Lange LA, Cushman M, Tracy RP, Reiner AP*. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Annals of Human Genetics 74,1–10, 2010. (PMCID:
2010 Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P, Dehghan A, Bis JC, Illig T, Morrison AC, Jenny NS, Keaney JF Jr, Gieger C, Tilley C, Yamamoto JF, Khuseyinova N, Heiss G, Doyle M, Blankenberg S, Herder C, Walston JD, Zhu Y, Vasan RS, Klopp N, Boerwinkle E, Larson MG, Psaty BM, Peters A, Ballantyne CM, Witteman JC, Hoogeveen RC, Benjamin EJ, Koenig W, Tracy RP. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood. 2010 Jul 1;115(26):5289-99.
For a complete list of Russel Tracy's publications, please visit PubMed.